Sandu Pharmaceuticals Ltd Share Price

Pharmaceuticals

BSE: 524703 Small Cap ISIN: INE751D01014

As on 18 November 2025 at 23:47 IST

Stock Not Traded in BSE

Over 1 Month

-2.97%

Over 6 Months

-22.42%

Over 1 Year

-25.32%

Over 3 Years

-34.31%

Sandu Pharmaceuticals Ltd Summary

Close ₹42.83

Open ₹45

High ₹45

Low ₹40.21

Volume 891

Net Turnover (in Cr) ₹0.0038

52Wk High ₹62.80

52Wk Low ₹40.21

52Wk High / Low

40.21

62.80

Sandu Pharmaceuticals Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹41.38

EPS (TTM) 1.69

Book Value (BV) 34.85

Div. Yield 1.87 %

P/E (TTM) 25.34

Price/Book Value 1.23

Delivery % 80.25 %

Face Value 10

Key Ratios

PE Ratio 30.62

PB Ratio 1.41

EV to Sales 0.66

PEG Ratio 5.14

ROA 3.65

ROE 4.74

Debt-Equity -

Net Profit Margin 2.31

Operating Profit Margin 4.36

Sandu Pharmaceuticals Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023
Total Revenue	67.36	67.70	65.68
Total Expenses	65.20	65.63	63.46
Profit Before Tax	2.16	2.07	2.22
Profit After Tax	1.55	1.46	1.52
Operating Profit After Depreciation	2.26	2.14	2.30

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023
Fixed Assets	18.15	17.88	16.62
Total Non Current Assets	29.42	30.11	28.62
Total Current Assets	26.30	22.30	25.55
Total Assets	55.72	52.41	54.17
Total Shareholder's Fund	42.02	40.59	39.24

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023
Net Cash From Operating Activities	0.95	0.76	0.22
Net Cash Used In Investing Activities	-0.19	-1.31	0.54
Net Cash Used In Financing Activities	-0.46	-0.72	0.58

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	67.36	67.70	65.68	65.58	58.95
Total Expenses	65.20	65.63	63.46	63.27	57.27
Profit Before Tax	2.16	2.07	2.22	2.32	1.68
Profit After Tax	1.55	1.46	1.52	1.59	1.09
Operating Profit After Depreciation	2.26	2.14	2.30	2.43	1.80

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	18.15	17.88	16.62	16	16.17
Total Non Current Assets	29.42	30.12	28.63	25.64	16.42
Total Current Assets	26.30	22.30	25.54	23.65	30.54
Total Assets	55.72	52.42	54.17	49.28	46.96
Total Shareholder's Fund	42.02	40.60	39.24	36.47	33.49

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	0.95	0.76	0.22	0.95	7.59
Net Cash Used In Investing Activities	-0.18	-1.31	0.53	-5.47	-5.58
Net Cash Used In Financing Activities	-0.46	-0.72	0.58	0.93	1.30

Particulars (in ₹ Cr.)	2025-03	2024-12	2024-09	2024-06	2024-03
Total Revenue	14.07	18.37	17.70	17.05	15.60
Total Expenses	13.62	17.38	16.80	16.64	14.99
Profit Before Tax	0.34	0.79	0.73	0.27	0.72
Profit After Tax	0.33	0.56	0.50	0.17	0.59
Operating Profit after Depreciation	0.52	1.01	0.93	0.45	0.92

Particulars (in ₹ Cr.)	2025-09	2025-06	2025-03	2024-12	2024-09
Total Revenue	17.62	16.70	14.07	18.37	17.70
Total Expenses	16.76	16.17	13.62	17.38	16.79
Profit Before Tax	0.71	0.34	0.34	0.79	0.74
Profit After Tax	0.52	0.22	0.33	0.56	0.50
Operating Profit after Depreciation	0.91	0.55	0.52	1.01	0.94

Sandu Pharmaceuticals Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 40.36

S2 37.89

S3 35.57

Pivot 42.68

R1 45.15

R2 47.47

R3 49.94

Moving Average

20 SMA 43.86

50 SMA 45.51

100 SMA 47.38

200 SMA 49.58

Sandu Pharmaceuticals Ltd Corporate Actions

Sandu Pharmaceuticals Ltd

₹0.8/Share

Announcement Date 18 Sep 2025

Record Date 18 Sep 2025

Div Yield 8%

AGM Date: 30 Sep 2021

AGM 30/09/2021 Outcome of the Board Meeting dated 14th August 2021 (As per BSE Announcement Dated on 14/08/201) Outcome of 36th Annual General Metting(As Per BSE Announcement Dated on 9/30/2021 7:57:48 AM) Voting Results and SCRUTINIZERS REPORT (As Per BSE announcement Dated on 01.10.2021)

AGM Date: 30 Sep 2022

To close Register of Members and Share Transfer Books of the Company from Saturday,24th September 2022 to Friday, 30th September 2022 both days inclusive. Intimation about Book closure Board Approves Dividend Intimation about the Annual General Meeting Summary of Outcome/Proceeding of the AGM /Disclosure of events or information under Regulation 30 of SEBI (LODR) Regulation -37th Annual General Meeting held on Friday, 30th September 2022 with Scrip Code 524703 OUTCOME OF THE 37th Annual General Meeting held on Friday,30th September 2022. Scrutinizers Report in respect of the 37th Annual General Meeting of the Company held on 30th September 2022 (As Per BSE Announcement Dated 01.10.2022)

AGM Date: 30 Sep 2023

Payment of Dividend for the year 2022-23 Rs 0.75 paisee per Share ( 7.5% of the paid up share capital of the Capital), if approved by the Shareholders and for conducting the Annual General Meeting to be held on 30th September 2023. Outcome of the Meeting (As Per BSE Announcement dated on 30.09.2023)

AGM Date: 30 Sep 2024

Outcome of the Board Meeting dated 12th August 2024 Outcome of the 39th Annual General Meeting (As Per BSE Announcement Dated on: 30/09/2024) Scrutinizers Report and Voting Results of Sandu Pharmaceuticals Limited 39th Annual General Meeting held on 30th September 2024 (As Per BSE Announcement Dated on: 01/10/2024)

AGM Date: 30 Sep 2025

AGM 30/09/2025 Outcome of the Board Meeting dated 13th August 2025. Voting results and Scrutinizers Report of the 40th Annual General Meeting held on 30th September 2025 Outcome of the 40th Annual General Meeting (As Per Bse Announcement dated on 30/09/2025) Announcement under Regulation 30-Agenda items Approved by Shareholders at the Annual General Meeting (As Per BSE Announcement Dated on:01.10.2025)

Sandu Pharmaceuticals Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,763.70	₹4,23,170.71
Divis Laboratories Ltd	₹6,523.25	₹1,73,171.79
Torrent Pharmaceuticals Ltd	₹3,816.75	₹1,29,170.36
Cipla Ltd	₹1,536.25	₹1,24,093.85
Dr Reddys Laboratories Ltd	₹1,244.50	₹1,03,868.61

Sandu Pharmaceuticals Ltd Top Mutal Funds Invested

No data available

Sandu Pharmaceuticals Ltd News

Sandu Pharmaceuticals schedules board meeting

On 12 November 2025

06 Nov 2025, 11:43 am

Sandu Pharmaceuticals to conduct board meeting

On 14 October 2025

04 Oct 2025, 05:36 pm

Sandu Pharmaceuticals to hold AGM

On 30 September 2025

14 Aug 2025, 02:43 pm

Sandu Pharmaceuticals announces board meeting date

On 13 August 2025

05 Aug 2025, 03:12 pm

Board of Sandu Pharmaceuticals recommends final dividend

Of Rs 0.8 per share

29 May 2025, 10:50 am

Sandu Pharmaceuticals Ltd Stock Analysis

Annual revenue for Sandu Pharmaceuticals Ltd decreased by 0.51% to ₹67.36 crore in FY 2025 from ₹67.70 crore in FY 2024.
Annual Net Profit for Sandu Pharmaceuticals Ltd increased by 6.04% to ₹1.55 crore in FY 2025 from ₹1.46 crore in FY 2024.
Promoter Shareholding in Sandu Pharmaceuticals Ltd remains unchanged by 0.00% in the most recent quarter, from 42.90% in June 2025 to 42.90% in September 2025.
Sandu Pharmaceuticals Ltd delivered a 1-year return of -25.32% compared to the Nifty 50, which provided a return of 10.91% as of the last trading session.
Sandu Pharmaceuticals Ltd share price moved down by 100.00% from its previous close of INR ₹42.83. The latest Sandu Pharmaceuticals Ltd share price is INR ₹0.
Sandu Pharmaceuticals Ltd share price today has been at a low of 40.21 and a high of 45. Over the past 52 weeks, the Sandu Pharmaceuticals Ltd share price has seen a low of 40.21 and a high of 62.80.